1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. ONYCHOMYCOSIS MARKET BY TYPE
5.1. Introduction
5.2. Distal Subungual Onychomycosis
5.3. White Superficial Onychomycosis
5.4. Proximal Subungual Onychomycosis
5.5. Others
6. ONYCHOMYCOSIS MARKET BY TREATMENT TYPE
6.1. Introduction
6.2. Oral
6.3. Topical
6.4. Others
7. ONYCHOMYCOSIS MARKET BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Institutional Sales
7.3. Retail Sales
8. ONYCHOMYCOSIS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Almirall
10.2. Onycho Pharma
10.3. Blue Cross NC
10.4. Hexima
10.5. Hallux Inc
10.6. Bausch Health
10.7. Canesten UK
10.8. Julbliarx
10.9. Ferozsons Laboratories Limited
10.10. Pfizer
10.11. Galderma
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES